Delivery Order SPE2DB20D3101-SPE2DB25FRVN9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (UU 30s) with a contract value of $8,928.96 under a firm fixed-price arrangement. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. This delivery order represents a non-set-aside, competitively awarded transaction that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $1,252.42 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and is scheduled for completion by July 25, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.59 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 master contract vehicle designed to supply pharmaceutical products and...
- The Defense Logistics Agency awarded a $4,358.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets in a quantity of 30 units. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a non-set-aside competitive award, and performance will be executed from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $134,109.38 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $5,171.85 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 18, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,373.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction supporting federal medical procurement needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVN9Delivery Order
The Defense Logistics Agency awarded a $2,879.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) under contract 4569461903. The award, announced on September 15, 2025, with completion targeted for September 16, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999.999 billion through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support role within the federal medical supply chain, where the company serves as a critical vendor for military and veteran healthcare systems. Vemlidy is a prescription antiviral medication used in the treatment of hepatitis B, reflecting the broad therapeutic range of pharmaceutical products AmerisourceBergen supplies through its DLA contracts, including specialty medications, vaccines, and medical devices. The firm fixed-price structure and rapid completion timeline demonstrate the operational efficiency characteristic of delivery orders executed under established indefinite delivery vehicles, enabling the federal government to access essential pharmaceutical inventory with minimal procurement lead time.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/15/25 |